Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : SARS - what next? -- Ignore unavailable to you. Want to Upgrade?

To: exdaytrader76 who wrote (385)	5/4/2003 6:17:48 AM
From: Ilaine	Respond to of 1070

I think they should try drugs designed to suppress Tumor Necrosis Factor Alpha (TNFa) - which already exist, created recently for rheumatoid arthritis - Remicade, Enbrel, Humira. Maybe this isn't something health care providers would try on ordinary patients, but given that maybe 25% of SARS patients are health care providers -- if I were one, I'd try it on myself. Maybe it will work, maybe it will be a death sentence. Either way, you're a hero for trying.